ERBB4 and neoplasm: In order to investigate the impact of the HER4 receptor on tumor growth and in the context of anti-hormonal and CDK4/6i therapy, humanized mice were transplanted with MCF-7 WT and MCF-7 HER4 knockout cells and treated with tamoxifen and abemaciclib, respectively (Supplementary Figure S4A).